We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CVS Health (CVS) Stock Moves -1.75%: What You Should Know
Read MoreHide Full Article
In the latest trading session, CVS Health (CVS - Free Report) closed at $89.85, marking a -1.75% move from the previous day. This change was narrower than the S&P 500's 3.25% loss on the day. At the same time, the Dow lost 2.42%, and the tech-heavy Nasdaq lost 0.49%.
Prior to today's trading, shares of the drugstore chain and pharmacy benefits manager had lost 2.73% over the past month. This has was narrower than the Retail-Wholesale sector's loss of 4.53% and the S&P 500's loss of 5.62% in that time.
CVS Health will be looking to display strength as it nears its next earnings release. In that report, analysts expect CVS Health to post earnings of $2.15 per share. This would mark a year-over-year decline of 11.16%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $76.53 billion, up 5.39% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $8.33 per share and revenue of $308.34 billion, which would represent changes of -0.83% and +5.56%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for CVS Health. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.13% higher. CVS Health currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, CVS Health is holding a Forward P/E ratio of 10.97. Its industry sports an average Forward P/E of 8.05, so we one might conclude that CVS Health is trading at a premium comparatively.
It is also worth noting that CVS currently has a PEG ratio of 1.44. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores industry currently had an average PEG ratio of 1.53 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 224, which puts it in the bottom 12% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CVS in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CVS Health (CVS) Stock Moves -1.75%: What You Should Know
In the latest trading session, CVS Health (CVS - Free Report) closed at $89.85, marking a -1.75% move from the previous day. This change was narrower than the S&P 500's 3.25% loss on the day. At the same time, the Dow lost 2.42%, and the tech-heavy Nasdaq lost 0.49%.
Prior to today's trading, shares of the drugstore chain and pharmacy benefits manager had lost 2.73% over the past month. This has was narrower than the Retail-Wholesale sector's loss of 4.53% and the S&P 500's loss of 5.62% in that time.
CVS Health will be looking to display strength as it nears its next earnings release. In that report, analysts expect CVS Health to post earnings of $2.15 per share. This would mark a year-over-year decline of 11.16%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $76.53 billion, up 5.39% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $8.33 per share and revenue of $308.34 billion, which would represent changes of -0.83% and +5.56%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for CVS Health. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.13% higher. CVS Health currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, CVS Health is holding a Forward P/E ratio of 10.97. Its industry sports an average Forward P/E of 8.05, so we one might conclude that CVS Health is trading at a premium comparatively.
It is also worth noting that CVS currently has a PEG ratio of 1.44. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores industry currently had an average PEG ratio of 1.53 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 224, which puts it in the bottom 12% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CVS in the coming trading sessions, be sure to utilize Zacks.com.